Cedara Software Corp. has formed a strategic partnership with Medipattern Corp. in Toronto. Under the terms of the agreement, Cedara will be the exclusive global channel for Medipattern's breast ultrasound computer aided diagnosis (CAD) and detection technology.
Cedara will also integrate Medipattern's CAD technology into its existing families of mammography and ultrasound products and will market these directly to end-users such as hospitals, imaging centers, radiologists and physicians, says Cedara.
The companies will work together in completing and commercializing the technology. In particular, Cedara says it will assist with marketing and product management; validation and engineering; regulatory management; technical authoring and hot-line support services. Cedara will also have a small equity stake in Medipattern.
Cedara Software recently announced Food and Drug Administration clearance of its Cedara I-ReadMammo mammography workstation, one of the first products that Cedara plans to enhance with Medipattern's new CAD technology.